Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole in acid-related chest pain
NCT00251901Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- May 2004
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of esomeprazole in non-cardiac chest pain (NCCP), sponsored by AstraZeneca. Started May 2004; status: completed.
02
Drugs
esomeprazole
03
Conditions
non-cardiac chest pain (NCCP)
Beyond the preview
Go deeper on NCT00251901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00251901.